Jannsen Covid-19 vaccine: EMA finds benefits outweigh risks of side-effects
The European Medicines Agency (EMA) safety committee (PRAC) concluded on April 20 that a warning about unusual blood clots with low blood platelets should be added to the product information for Covid-19 Vaccine Janssen, the agency said in a media statement. PRAC also concluded that these events should be listed as “very rare” side effects of the vaccine, the EMA said. The committee took into consideration all currently available evidence including eight reports from the United States of serious cases of unusual blood clots associated with low levels of blood platelets, one of which had...